Company Filing History:
Years Active: 2005
Title: Mary Goldring: Innovator in Inflammation Treatment
Introduction
Mary Goldring is a notable inventor based in Auburndale, MA (US). She has made significant contributions to the field of medical research, particularly in the treatment of inflammation and related diseases. Her innovative approach utilizes transcription factors to address various health issues.
Latest Patents
Mary Goldring holds 1 patent for her invention titled "Use of transcription factors for treating inflammation and other diseases." This patent outlines a method for treating inflammation in mammals by altering the activity of transcription factors involved in the inflammatory response. Additionally, her invention includes the use of transcription factors to screen compounds that can reduce inflammation. It also provides methods for diagnosing inflammatory diseases in mammalian tissues and monitoring treatment effectiveness.
Career Highlights
Mary Goldring is affiliated with Beth Israel Deaconess Medical Center, Inc., where she continues her research and development efforts. Her work has been instrumental in advancing the understanding of inflammation and its treatment.
Collaborations
Mary has collaborated with esteemed colleagues such as Peter Oettgen and Towia Aron Libermann, contributing to a rich environment of innovation and research.
Conclusion
Mary Goldring's contributions to the field of inflammation treatment through her innovative use of transcription factors highlight her role as a leading inventor in medical research. Her work continues to pave the way for advancements in the diagnosis and treatment of inflammatory diseases.